119 results
Page 5 of 6
424B5
em1ts1u8 dfpi
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
3vfaogkiz lr
3 Mar 14
Current report (foreign)
12:00am
6-K
EX-99
u45rlpi wnh65gq11vec
23 Jan 14
BioLineRx Receives Orphan Drug
12:00am
6-K
EX-99
mrbo222zoiour7timg
13 Jan 14
Current report (foreign)
12:00am
6-K
EX-99
ewnjj bc0mumtyif6h
16 Dec 13
BioLineRx Announces Promising Initial Phase 2
12:00am
6-K
EX-99
8bkznsan
10 Dec 13
BioLineRx Presents Positive Preclinical Results of
12:00am
6-K
EX-99
fy0d4d1o
19 Nov 13
BioLineRx Reports Publication in Peer Review Journal
12:00am
6-K
EX-99
zo1erw qjka0d5h9l
9 Sep 13
BioLineRx’s BL-8040 Receives Orphan Drug
12:00am
6-K
EX-99
4h3x1o4g2d 68si1
3 Sep 13
BioLineRx Announces Issuance of United States Patent
12:00am
424B3
vfjiy
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
zjy7 gihzxowq9lcs4b
6 Aug 13
BioLineRx Reports Second Quarter 2013 Results
12:00am
6-K
EX-99
p28g0 haih9wvtx7
5 Aug 13
BioLineRx Announces Publication of Positive
12:00am
6-K
EX-99
l04xl15oxst0hmqoo99j
6 Jun 13
Current report (foreign)
12:00am
6-K
EX-99
a0o8svlxcdye7
7 May 13
BioLineRx Reports First Quarter 2013 Results
12:00am
6-K
EX-99
3wn vlxukiyg
10 Apr 13
BioLineRx Receives Regulatory Approval to Commence
12:00am
424B5
s0x5j 1504yydyio8d
6 Feb 13
Prospectus supplement for primary offering
12:00am
424B3
mjd62o c2tsclbk
15 Oct 12
Prospectus supplement
12:00am
F-1
1hv85s8l6n
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99.1
h286c7sbubauvu7b
4 Sep 12
Current report (foreign)
12:00am